Oragenics News, Oragenics Quote, OGEN Quote

Oragenics (NY:OGEN) Delayed: 1.06 -0.03 (2.75%)

Prev. Close

$1.09

Open

$1.10

52 Wk High

$2.12

52 Wk Low

$0.33

Day High

$1.15

Day Low

$1.05

P/E

N/A

EPS

$-0.45

Volume

61,782

Friends, Peers and Foes (?): ODYY (more...)

Apr 22, 2024 06:02 AM Form 8-K ORAGENICS INC For: Apr 18
Apr 19, 2024 05:50 PM Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
Apr 16, 2024 06:03 AM Form 8-K ORAGENICS INC For: Apr 15
Apr 1, 2024 09:07 AM Oragenics (OGEN) Files 10K, Provides Company Update
Apr 1, 2024 09:05 AM Oragenics, Inc. Files 10K and Provides Company Update
Mar 29, 2024 04:17 PM Form 10-K ORAGENICS INC For: Dec 31
Mar 18, 2024 07:39 AM Form 8-K ORAGENICS INC For: Mar 18
Mar 18, 2024 07:07 AM Oragenics (OGEN) Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion
Mar 18, 2024 07:00 AM Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion
Mar 6, 2024 04:56 PM Form SC 13G ORAGENICS INC Filed by: Lind Global Fund II LP

Entities mentioned with OGEN